BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: GBD 2017 Stomach Cancer Collaborators. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017. Lancet Gastroenterol Hepatol. 2020;5:42-54. [PMID: 31648970 DOI: 10.1016/s2468-1253(19)30328-0] [Cited by in Crossref: 89] [Cited by in F6Publishing: 55] [Article Influence: 29.7] [Reference Citation Analysis]
Number Citing Articles
1 Chen Q, Lin L, Xiong B, Yang W, Huang J, Shi H, Wang Z. MiR-873-5p targets THUMPD1 to inhibit gastric cancer cell behavior and chemoresistance. J Gastrointest Oncol 2021;12:2061-72. [PMID: 34790374 DOI: 10.21037/jgo-21-641] [Reference Citation Analysis]
2 Shu X, Cai H, Lan Q, Cai Q, Ji BT, Zheng W, Shu XO. A Prospective Investigation of Circulating Metabolome Identifies Potential Biomarkers for Gastric Cancer Risk. Cancer Epidemiol Biomarkers Prev 2021;30:1634-42. [PMID: 33795214 DOI: 10.1158/1055-9965.EPI-20-1633] [Reference Citation Analysis]
3 Corso G, Corso F, Bellerba F, Carneiro P, Seixas S, Cioffi A, La Vecchia C, Magnoni F, Bonanni B, Veronesi P, Gandini S, Figueiredo J. Geographical Distribution of E-cadherin Germline Mutations in the Context of Diffuse Gastric Cancer: A Systematic Review. Cancers (Basel) 2021;13:1269. [PMID: 33809393 DOI: 10.3390/cancers13061269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Deng C, Liu Y, Zhang ZY, Qi HD, Guo Z, Zhao X, Li XJ. How to examine anastomotic integrity intraoperatively in totally laparoscopic radical gastrectomy? Methylene blue testing prevents technical defect-related anastomotic leaks . World J Gastrointest Surg 2022; 14(4): 315-328 [DOI: 10.4240/wjgs.v14.i4.315] [Reference Citation Analysis]
5 da Silva EL, Mesquita FP, de Sousa Portilho AJ, Bezerra ECA, Daniel JP, Aranha ESP, Farran S, de Vasconcellos MC, de Moraes MEA, Moreira-Nunes CA, Montenegro RC. Differences in glucose concentration shows new perspectives in gastric cancer metabolism. Toxicol In Vitro 2022;:105357. [PMID: 35427737 DOI: 10.1016/j.tiv.2022.105357] [Reference Citation Analysis]
6 Li Y, Song S, Pizzi MP, Han G, Scott AW, Jin J, Xu Y, Wang Y, Huo L, Ma L, Vellano C, Luo X, MacLeod R, Wang L, Wang Z, Ajani JA. LncRNA PVT1 Is a Poor Prognosticator and Can Be Targeted by PVT1 Antisense Oligos in Gastric Adenocarcinoma. Cancers (Basel) 2020;12:E2995. [PMID: 33076512 DOI: 10.3390/cancers12102995] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Teng JJ, Zhao WJ, Zhang XL, Zhao DK, Qiu XY, Chen XD, Yang L. Downregulation of promoter methylation gene PRDM5 contributes to the development of tumor proliferation and predicts poor prognosis in gastric cancer. J Cancer 2021;12:6921-30. [PMID: 34659579 DOI: 10.7150/jca.59998] [Reference Citation Analysis]
8 Zhou L, Yu Q, Wei G, Wang L, Huang Y, Hu K, Hu Y, Huang H. Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019. BMC Cancer 2021;21:606. [PMID: 34034700 DOI: 10.1186/s12885-021-08280-y] [Reference Citation Analysis]
9 Yano Y, Abnet CC, Poustchi H, Roshandel G, Pourshams A, Islami F, Khoshnia M, Amiriani T, Norouzi A, Kamangar F, Boffetta P, Brennan P, Dawsey SM, Vogtmann E, Malekzadeh R, Etemadi A. Oral Health and Risk of Upper Gastrointestinal Cancers in a Large Prospective Study from a High-risk Region: Golestan Cohort Study. Cancer Prev Res (Phila) 2021;14:709-18. [PMID: 33731409 DOI: 10.1158/1940-6207.CAPR-20-0577] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Müller B, García C, Sola JA, Fernandez W, Werner P, Cerda M, Slater J, Benavides C, Arancibia J, Ascui R, Reyes F, Stevens MA, Miranda JP, Buchholtz M, Corvalan AH. Perioperative chemotherapy in locally advanced gastric cancer in Chile: from evidence to daily practice. Ecancermedicalscience 2021;15:1244. [PMID: 34267800 DOI: 10.3332/ecancer.2021.1244] [Reference Citation Analysis]
11 Huang RJ, Hwang JH. Improving the Early Diagnosis of Gastric Cancer. Gastrointest Endosc Clin N Am 2021;31:503-17. [PMID: 34053636 DOI: 10.1016/j.giec.2021.03.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Huang RJ, Epplein M, Hamashima C, Choi IJ, Lee E, Deapen D, Woo Y, Tran T, Shah SC, Inadomi JM, Greenwald DA, Hwang JH. An Approach to the Primary and Secondary Prevention of Gastric Cancer in the United States. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01054-5. [PMID: 34624563 DOI: 10.1016/j.cgh.2021.09.039] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wu X, Li D, Chen H, Han J, Zhou H, He Z, Ma Y, Dong B, Wu Y, Matkowskyj KA, Ejaz A, Almhanna K, Wang Q. Evaluation of the reporting quality of guidelines for gastric cancer using the RIGHT checklist. Ann Transl Med 2021;9:1003. [PMID: 34277803 DOI: 10.21037/atm-21-2491] [Reference Citation Analysis]
14 Zeng F, Chen L, Liao M, Chen B, Long J, Wu W, Deng G. Laparoscopic versus open gastrectomy for gastric cancer. World J Surg Oncol 2020;18:20. [PMID: 31987046 DOI: 10.1186/s12957-020-1795-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
15 Wong IOL, Lam YT, Lam KF, Cowling BJ, Leung GM. Demographic and Epidemiological Contributions to Recent Trends in Cancer Incidence in Hong Kong. Cancers (Basel) 2021;13:5727. [PMID: 34830881 DOI: 10.3390/cancers13225727] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Lu X, Zhang M, Wei C, Wang Z, Zheng Q, Yu C. The Impact of a Simplified Scoring System on Long-Term Survival Outcomes in Patients with Gastric Cancer Undergoing Gastrectomy. Nutr Cancer 2021;:1-8. [PMID: 34809498 DOI: 10.1080/01635581.2021.2005807] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Huang HL, Leung CY, Saito E, Katanoda K, Hur C, Kong CY, Nomura S, Shibuya K. Effect and cost-effectiveness of national gastric cancer screening in Japan: a microsimulation modeling study. BMC Med 2020;18:257. [PMID: 32921305 DOI: 10.1186/s12916-020-01729-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Yue Y, Lin X, Qiu X, Yang L, Wang R. The Molecular Roles and Clinical Implications of Non-Coding RNAs in Gastric Cancer. Front Cell Dev Biol 2021;9:802745. [PMID: 34966746 DOI: 10.3389/fcell.2021.802745] [Reference Citation Analysis]
19 Yoo SH, Kang SY, Yoon J, Kim TY, Cheon GJ, Oh DY. Prospective evaluation of metabolic intratumoral heterogeneity in patients with advanced gastric cancer receiving palliative chemotherapy. Sci Rep 2021;11:296. [PMID: 33436659 DOI: 10.1038/s41598-020-78963-2] [Reference Citation Analysis]
20 Xing QQ, Li JM, Dong X, Zeng DY, Chen ZJ, Lin XY, Pan JS. Socioeconomics and attributable etiology of primary liver cancer, 1990-2019. World J Gastroenterol 2022; 28(21): 2361-2382 [DOI: 10.3748/wjg.v28.i21.2361] [Reference Citation Analysis]
21 You Y, Thorell K, He L, Yahara K, Yamaoka Y, Cha J, Murakami K, Katsura Y, Kobayashi I, Falush D, Zhang J; TEAMHp. Genomic differentiation within East Asian Helicobacter pylori. Microbial Genomics 2022;8. [DOI: 10.1099/mgen.0.000676] [Reference Citation Analysis]
22 He J, Fu H, Li C, Deng Z, Chang H. Association between Vitamin B12 and Risk of Gastric Cancer: A Systematic Review and Meta-Analysis of Epidemiological Studies. Nutr Cancer 2022;:1-11. [PMID: 35538710 DOI: 10.1080/01635581.2022.2074062] [Reference Citation Analysis]
23 Guo Z, Liang E, Li W, Jiang L, Zhi F. Essential meiotic structure-specific endonuclease1 (EME1) promotes malignant features in gastric cancer cells via the Akt/GSK3B/CCND1 pathway. Bioengineered 2021. [PMID: 34719326 DOI: 10.1080/21655979.2021.1999371] [Reference Citation Analysis]
24 Kwon MJ, Kim JN, Park J, Kim YT, Lee MJ, Kim BJ. Alisma canaliculatum Extract Affects AGS Gastric Cancer Cells by Inducing Apoptosis. Int J Med Sci 2021;18:2155-61. [PMID: 33859522 DOI: 10.7150/ijms.55212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Wang S, Ye F, Sheng Y, Yu W, Liu Y, Liu D, Zhang K. Development and Validation of Nomograms to Predict Operative Link for Gastritis Assessment Any-Stage and Stages III-IV in the Chinese High-Risk Gastric Cancer Population. Front Med (Lausanne) 2021;8:724566. [PMID: 34447771 DOI: 10.3389/fmed.2021.724566] [Reference Citation Analysis]
26 Mannion A, Dzink-Fox J, Shen Z, Piazuelo MB, Wilson KT, Correa P, Peek RM Jr, Camargo MC, Fox JG. Helicobacter pylori Antimicrobial Resistance and Gene Variants in High- and Low-Gastric-Cancer-Risk Populations. J Clin Microbiol 2021;59:e03203-20. [PMID: 33692136 DOI: 10.1128/JCM.03203-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Asplund J, Gottlieb-Vedi E, Leijonmarck W, Mattsson F, Lagergren J. Prognosis after surgery for gastric adenocarcinoma in the Swedish Gastric Cancer Surgery Study (SWEGASS). Acta Oncol 2021;60:513-20. [PMID: 33502275 DOI: 10.1080/0284186X.2021.1874619] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
28 Accordino G, Lettieri S, Bortolotto C, Benvenuti S, Gallotti A, Gattoni E, Agustoni F, Pozzi E, Rinaldi P, Primiceri C, Morbini P, Lancia A, Stella GM. From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers-A Multidisciplinary Perspective. Cancers (Basel) 2020;12:E2105. [PMID: 32751137 DOI: 10.3390/cancers12082105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Bednarz-Misa I, Fortuna P, Diakowska D, Jamrozik N, Krzystek-Korpacka M. Distinct Local and Systemic Molecular Signatures in the Esophageal and Gastric Cancers: Possible Therapy Targets and Biomarkers for Gastric Cancer. Int J Mol Sci 2020;21:E4509. [PMID: 32630408 DOI: 10.3390/ijms21124509] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
30 Ilic M, Ilic I. Epidemiology of stomach cancer. World J Gastroenterol 2022; 28(12): 1187-1203 [DOI: 10.3748/wjg.v28.i12.1187] [Reference Citation Analysis]
31 Li Y, Huang Y, He X, Han C, Wu W, Shen H, Xu Y, Liu Y, Zhu Z. The global burden of thyroid cancer in high-income Asia-Pacific: a systematic analysis of the Global Burden of Disease study. Therapeutic Advances in Endocrinology 2022;13:204201882210900. [DOI: 10.1177/20420188221090012] [Reference Citation Analysis]
32 Wong MCS, Huang J, Chan PSF, Choi P, Lao XQ, Chan SM, Teoh A, Liang P. Global Incidence and Mortality of Gastric Cancer, 1980-2018. JAMA Netw Open 2021;4:e2118457. [PMID: 34309666 DOI: 10.1001/jamanetworkopen.2021.18457] [Reference Citation Analysis]
33 Braga-Neto MB, Costa DVS, Queiroz DMM, Maciel FS, de Oliveira MS, Viana-Junior AB, Santos FA, Leitao RFC, Brito GAC, Vasconcelos PRL, Braga LLBC. Increased Oxidative Stress in Gastric Cancer Patients and Their First-Degree Relatives: A Prospective Study from Northeastern Brazil. Oxid Med Cell Longev 2021;2021:6657434. [PMID: 34873431 DOI: 10.1155/2021/6657434] [Reference Citation Analysis]
34 Teng F, Zhang JX, Chen Y, Shen XD, Su C, Guo YJ, Wang PH, Shi CC, Lei M, Cao YO, Liu SQ. LncRNA NKX2-1-AS1 promotes tumor progression and angiogenesis via upregulation of SERPINE1 expression and activation of the VEGFR-2 signaling pathway in gastric cancer. Mol Oncol 2021;15:1234-55. [PMID: 33512745 DOI: 10.1002/1878-0261.12911] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
35 Yang X, Zhang T, Zhang H, Sang S, Chen H, Zuo X. Temporal trend of gastric cancer burden along with its risk factors in China from 1990 to 2019, and projections until 2030: comparison with Japan, South Korea, and Mongolia. Biomark Res 2021;9:84. [PMID: 34784961 DOI: 10.1186/s40364-021-00340-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Young E, Philpott H, Singh R. Endoscopic diagnosis and treatment of gastric dysplasia and early cancer: Current evidence and what the future may hold. World J Gastroenterol 2021; 27(31): 5126-5151 [PMID: 34497440 DOI: 10.3748/wjg.v27.i31.5126] [Reference Citation Analysis]
37 Kabiri N, Khodayari‐zarnaq R, Khoshbaten M, Janati A. Policy Analysis of Gastrointestinal Cancer Prevention in Iran: A Framework Based on a Qualitative Study. World Medical & Health Policy 2021;13:548-70. [DOI: 10.1002/wmh3.389] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Du S, Fang Z, Ye L, Sun H, Deng G, Wu W, Zeng F. Pretreatment neutrophil-to-lymphocyte ratio predicts the benefit of gastric cancer patients with systemic therapy. Aging (Albany NY) 2021;13:17638-54. [PMID: 34245559 DOI: 10.18632/aging.203256] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Zu H, Wang H, Li C, Zhu W, Xue Y. The Predictive and Prognostic Factors in Patients with Gastric Cancer Accompanied by Gastric Outlet Obstruction. Gastroenterol Res Pract 2020;2020:6529563. [PMID: 32774358 DOI: 10.1155/2020/6529563] [Reference Citation Analysis]
40 Zhu C, Platoff R, Ghobrial G, Saddemi J, Evangelisti T, Bucher E, Saracco B, Adams A, Kripalani S, Atabek U, Spitz FR, Hong YK. What to do When Decompressive Gastrostomies and Jejunostomies are not Options? A Scoping Review of Transesophageal Gastrostomy Tubes for Advanced Malignancies. Ann Surg Oncol 2021. [PMID: 34546480 DOI: 10.1245/s10434-021-10667-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Wirth K, Näpflin M, Graber SM, Blozik E. Does hospital volume affect outcomes after abdominal cancer surgery: an analysis of Swiss health insurance claims data. BMC Health Serv Res 2022;22. [DOI: 10.1186/s12913-022-07513-5] [Reference Citation Analysis]
42 Huo J, Wu L, Zang Y. Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer. J Immunol Res 2021;2021:5554342. [PMID: 34007851 DOI: 10.1155/2021/5554342] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Jeong J, Kim DK, Park JH, Park DJ, Lee HJ, Yang HK, Kong SH, Jung K. Tumor-Infiltrating Neutrophils and Non-Classical Monocytes May Be Potential Therapeutic Targets for HER2negative Gastric Cancer. Immune Netw 2021;21:e31. [PMID: 34522444 DOI: 10.4110/in.2021.21.e31] [Reference Citation Analysis]
44 Huang Q, Zheng X, Jiao Y, Lei Y, Li X, Bi F, Guo F, Wang G, Liu M. A Distinct Clinicopathological Feature and Prognosis of Young Gastric Cancer Patients Aged ≤ 45 Years Old. Front Oncol 2021;11:674224. [PMID: 34513668 DOI: 10.3389/fonc.2021.674224] [Reference Citation Analysis]
45 Bang S, Jee S, Kim H, Jang K, Park H, Myung JK, Choi D, Shin SJ, Paik SS. Low DUSP4 Expression Is Associated With Aggressive Phenotypes and Poor Prognosis in Gastric Cancer. In Vivo 2021;35:131-40. [PMID: 33402458 DOI: 10.21873/invivo.12240] [Reference Citation Analysis]
46 Maheshwari U, Sharma M, Goel V, Goyal P, Jain P, Agarwal C, Jajodia A, Talwar V, Bp A, Joga S, Doval DC, Pasricha S, Koyyala VPB. Clinical Profile and Outcomes of Treatment in Gastric Cancer in Young Patients in India. Asian Journal of Oncology. [DOI: 10.1055/s-0042-1744451] [Reference Citation Analysis]
47 McNamara KM, Gobert AP, Wilson KT. The role of polyamines in gastric cancer. Oncogene 2021;40:4399-412. [PMID: 34108618 DOI: 10.1038/s41388-021-01862-x] [Reference Citation Analysis]
48 Lu W, Ni Z, Jiang S, Tong M, Zhang J, Zhao J, Feng C, Jia Q, Wang J, Yao T, Ning H, Shi Y. Resveratrol inhibits bile acid-induced gastric intestinal metaplasia via the PI3K/AKT/p-FoxO4 signalling pathway. Phytother Res 2021;35:1495-507. [PMID: 33103284 DOI: 10.1002/ptr.6915] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
49 Bajoghli AA, Piselli A, Kemprecos H, Khosravi H, Cardis MA, Noel MS. Gastric carcinoma's primary presentation as multiple cutaneous nodules throughout the body. Cancer Treatment and Research Communications 2022. [DOI: 10.1016/j.ctarc.2022.100532] [Reference Citation Analysis]
50 Li Y, Tian Z, Tan Y, Lian G, Chen S, Chen S, Li J, Li X, Huang K, Chen Y. Bmi-1-induced miR-27a and miR-155 promote tumor metastasis and chemoresistance by targeting RKIP in gastric cancer. Mol Cancer 2020;19:109. [PMID: 32580736 DOI: 10.1186/s12943-020-01229-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
51 Rabben HL, Andersen GT, Ianevski A, Olsen MK, Kainov D, Grønbech JE, Wang TC, Chen D, Zhao CM. Computational Drug Repositioning and Experimental Validation of Ivermectin in Treatment of Gastric Cancer. Front Pharmacol 2021;12:625991. [PMID: 33867984 DOI: 10.3389/fphar.2021.625991] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Liu X, Ma B, Chen M, Zhang Y, Ma Z, Chen H. Prognostic Autophagy-Related Genes of Gastric Cancer Patients on Chemotherapy. Front Genet 2021;12:720849. [PMID: 34759953 DOI: 10.3389/fgene.2021.720849] [Reference Citation Analysis]
53 Fu L, Feng X, Jin Y, Lu Z, Li R, Xu W, Chang VT, Hu Y, Ye X. Symptom Clusters and Quality of Life in Gastric Cancer Patients Receiving Chemotherapy. J Pain Symptom Manage 2021:S0885-3924(21)00525-X. [PMID: 34537311 DOI: 10.1016/j.jpainsymman.2021.09.003] [Reference Citation Analysis]
54 Sun J, Shen D, Gao Y, Zheng Y, Zhao L, Maa M, Liu H, Chen X. Down-Regulation of USP8 Suppresses HER-3 Positive Gastric Cancer Cells Proliferation. Onco Targets Ther 2020;13:7973-84. [PMID: 32848421 DOI: 10.2147/OTT.S264108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Luo J, Jiang Y, Chen X, Chen Y, Gurung JL, Mou T, Zhao L, Lyu G, Li T, Li G, Yu J. Prognostic value and nomograms of proximal margin distance in gastric cancer with radical distal gastrectomy. Chin J Cancer Res 2020;32:186-96. [PMID: 32410796 DOI: 10.21147/j.issn.1000-9604.2020.02.06] [Reference Citation Analysis]
56 Marlicz W, Ren X, Robertson A, Skonieczna-Żydecka K, Łoniewski I, Dario P, Wang S, Plevris JN, Koulaouzidis A, Ciuti G. Frontiers of Robotic Gastroscopy: A Comprehensive Review of Robotic Gastroscopes and Technologies. Cancers (Basel) 2020;12:E2775. [PMID: 32998213 DOI: 10.3390/cancers12102775] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
57 Liu J, Liu Y, Zhang Y, Zheng J, Wang S, Chen G, Cao G. Circular RNA hsa_circ_0004543 Aggravates Cervical Cancer Development by Sponging MicroRNA hsa-miR-217 to Upregulate Hypoxia-Inducible Factor. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/4031403] [Reference Citation Analysis]
58 Zhang T, Chen H, Yin X, He Q, Man J, Yang X, Lu M. Changing trends of disease burden of gastric cancer in China from 1990 to 2019 and its predictions: Findings from Global Burden of Disease Study. Chin J Cancer Res 2021;33:11-26. [PMID: 33707924 DOI: 10.21147/j.issn.1000-9604.2021.01.02] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 de la Fouchardiere C, Decoster L, Samalin E, Terret C, Kenis C, Droz JP, Coutzac C, Smyth E. Advanced oesophago-gastric adenocarcinoma in older patients in the era of immunotherapy. A review of the literature. Cancer Treat Rev 2021;100:102289. [PMID: 34583303 DOI: 10.1016/j.ctrv.2021.102289] [Reference Citation Analysis]
60 Zhao E, Feng L, Bai L, Cui H. NUCKS promotes cell proliferation and suppresses autophagy through the mTOR-Beclin1 pathway in gastric cancer. J Exp Clin Cancer Res 2020;39:194. [PMID: 32958058 DOI: 10.1186/s13046-020-01696-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
61 Park JC. Changing trends in gastric cancer incidence and mortality: the role of upper endoscopy in low-risk countries. Endoscopy 2022. [PMID: 35213899 DOI: 10.1055/a-1759-2829] [Reference Citation Analysis]
62 Díaz Del Arco C, Ortega Medina L, Estrada Muñoz L, Molina Roldán E, Cerón Nieto MÁ, García Gómez de Las Heras S, Fernández Aceñero MJ. Are Borrmann's Types of Advanced Gastric Cancer Distinct Clinicopathological and Molecular Entities? A Western Study. Cancers (Basel) 2021;13:3081. [PMID: 34205546 DOI: 10.3390/cancers13123081] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
63 Xi D, Jia Q, Liu X, Zhang L, Xu B, Ma Z, Ma Y, Yu Y, Zhang F, Chen H. LAMC1 is a Novel Prognostic Factor and a Potential Therapeutic Target in Gastric Cancer. IJGM 2022;Volume 15:3183-98. [DOI: 10.2147/ijgm.s353289] [Reference Citation Analysis]
64 Dai J, Nishi A, Li ZX, Zhang Y, Zhou T, You WC, Li WQ, Pan KF. DNA methylation signatures associated with prognosis of gastric cancer. BMC Cancer 2021;21:610. [PMID: 34034702 DOI: 10.1186/s12885-021-08389-0] [Reference Citation Analysis]
65 Ge J, Liu T, Lei T, Li X, Song K, Azizi S, Liu H, Tang M. Retrospective Cohort Study of Intraoperative Administration of Sustained-Release 5-Fluorouracil Implants in Advanced Gastric Cancer Patients. Front Pharmacol 2021;12:659258. [PMID: 33927633 DOI: 10.3389/fphar.2021.659258] [Reference Citation Analysis]
66 Aumpan N, Vilaichone RK, Pornthisarn B, Chonprasertsuk S, Siramolpiwat S, Bhanthumkomol P, Nunanan P, Issariyakulkarn N, Ratana-Amornpin S, Miftahussurur M, Mahachai V, Yamaoka Y. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial). PLoS One 2021;16:e0255601. [PMID: 34379655 DOI: 10.1371/journal.pone.0255601] [Reference Citation Analysis]
67 Doohan D, Rezkitha YAA, Waskito LA, Vilaichone R, Yamaoka Y, Miftahussurur M. Integrating microbiome, transcriptome and metabolome data to investigate gastric disease pathogenesis: a concise review. Expert Rev Mol Med 2021;23. [DOI: 10.1017/erm.2021.8] [Reference Citation Analysis]
68 Kanno T, Moayyedi P. Who Needs Gastroprotection in 2020? Curr Treat Options Gastroenterol 2020;:1-17. [PMID: 33199955 DOI: 10.1007/s11938-020-00316-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
69 Ford AC, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis. Gut 2020;69:2113-21. [PMID: 32205420 DOI: 10.1136/gutjnl-2020-320839] [Cited by in Crossref: 80] [Cited by in F6Publishing: 61] [Article Influence: 40.0] [Reference Citation Analysis]
70 Cao F, Zheng Y, Yang C, Huang S, He X, Tong S, Khalaf OI. +HOXA10-AS Promotes Malignant Phenotypes of Gastric Cancer via Upregulating HOXA10. Computational and Mathematical Methods in Medicine 2022;2022:1-10. [DOI: 10.1155/2022/1846687] [Reference Citation Analysis]
71 Xiao S, Zhou L. Gastric Stem Cells: Physiological and Pathological Perspectives. Front Cell Dev Biol 2020;8:571536. [PMID: 33043003 DOI: 10.3389/fcell.2020.571536] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
72 Yang Y, Ma Y, Xiang X, Xing P, Wu Y, Zhang L, Tian Y. The prognostic value of the lymph node ratio for local advanced gastric cancer patients with intensity-modulated radiation therapy and concurrent chemotherapy after radical gastrectomy in China. Radiat Oncol 2020;15:237. [PMID: 33054848 DOI: 10.1186/s13014-020-01687-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
73 Mansorunov D, Apanovich N, Apanovich P, Kipkeeva F, Muzaffarova T, Kuzevanova A, Nikulin M, Malikhova O, Karpukhin A. Expression of Immune Checkpoints in Malignant Tumors: Therapy Targets and Biomarkers for the Gastric Cancer Prognosis. Diagnostics (Basel) 2021;11:2370. [PMID: 34943606 DOI: 10.3390/diagnostics11122370] [Reference Citation Analysis]
74 Prasad P, Sivaharan A, Navidi M, Fergie BH, Griffin SM, Phillips AW. Significance of neoadjuvant downstaging in gastric adenocarcinoma. Surgery 2022. [DOI: 10.1016/j.surg.2022.03.005] [Reference Citation Analysis]
75 Irino T, Matsuda S, Wada N, Kawakubo H, Kitagawa Y. Essential updates 2019/2020: Perioperative and surgical management of gastric cancer. Ann Gastroenterol Surg 2021;5:162-72. [PMID: 33860136 DOI: 10.1002/ags3.12438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Khalafi S, Zhu S, Khurana R, Lohse I, Giordano S, Corso S, Al-Ali H, Brothers SP, Wahlestedt C, Schürer S, El-Rifai W. A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer. Transl Oncol 2021;15:101260. [PMID: 34735897 DOI: 10.1016/j.tranon.2021.101260] [Reference Citation Analysis]
77 Wang Y, Zhai J, Zhang T, Han S, Zhang Y, Yao X, Shen L. Tumor-Associated Neutrophils Can Predict Lymph Node Metastasis in Early Gastric Cancer. Front Oncol 2020;10:570113. [PMID: 33072602 DOI: 10.3389/fonc.2020.570113] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
78 Du S, Yang Y, Fang S, Guo S, Xu C, Zhang P, Wei W. Gastric Cancer Risk of Intestinal Metaplasia Subtypes: A Systematic Review and Meta-Analysis of Cohort Studies. Clin Transl Gastroenterol 2021;12:e00402. [PMID: 34597278 DOI: 10.14309/ctg.0000000000000402] [Reference Citation Analysis]
79 Wu Y, Zheng J, Yan Y, Liu J, Zhou Y. Gelsolin Can Be a Prognostic Biomarker and Correlated with Immune Infiltrates in Gastric Cancer. IJGM 2022;Volume 15:927-36. [DOI: 10.2147/ijgm.s339940] [Reference Citation Analysis]
80 Chen J, Chen H, Zhang T, Yin X, Man J, Yang X, Lu M. Burden of pancreatic cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030. Pancreatology 2022. [DOI: 10.1016/j.pan.2022.04.011] [Reference Citation Analysis]
81 Acikgoz Y, Aktürk Esen S, Ucar G, Dirikoc M, Ergun Y, Bal O, Uncu D. The Comparison of mDCF and mFOLFOX-6 as First-Line Treatment in Metastatic Gastric Cancer. Cureus 2021;13:e14882. [PMID: 34104608 DOI: 10.7759/cureus.14882] [Reference Citation Analysis]
82 Qin Y, Tong X, Fan J, Liu Z, Zhao R, Zhang T, Suo C, Chen X, Zhao G. Global Burden and Trends in Incidence, Mortality, and Disability of Stomach Cancer From 1990 to 2017. Clin Transl Gastroenterol 2021;12:e00406. [PMID: 34608884 DOI: 10.14309/ctg.0000000000000406] [Reference Citation Analysis]
83 Emanuele Liardo RL, Borzì AM, Spatola C, Martino B, Privitera G, Basile F, Biondi A, Vacante M. Effects of infections on the pathogenesis of cancer. Indian J Med Res 2021;153:431-45. [PMID: 34380789 DOI: 10.4103/ijmr.IJMR_339_19] [Reference Citation Analysis]
84 Zhang T, Chen H, Zhang Y, Yin X, Man J, Yang X, Lu M. Global changing trends in incidence and mortality of gastric cancer by age and sex, 1990-2019: Findings from Global Burden of Disease Study. J Cancer 2021;12:6695-705. [PMID: 34659559 DOI: 10.7150/jca.62734] [Reference Citation Analysis]
85 Xie J, Pang Y, Li X, Wu X. The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients. J Cancer Res Clin Oncol 2021;147:2259-69. [PMID: 34003367 DOI: 10.1007/s00432-021-03654-y] [Reference Citation Analysis]
86 Liu D, Chen S, Gou Y, Yu W, Zhou H, Zhang R, Wang J, Ye F, Liu Y, Sun B, Zhang K. Gastrointestinal Microbiota Changes in Patients With Gastric Precancerous Lesions. Front Cell Infect Microbiol 2021;11:749207. [PMID: 34956928 DOI: 10.3389/fcimb.2021.749207] [Reference Citation Analysis]
87 Crawford K, Bontrager E, Schwarz MA, Chaturvedi A, Lee DD, Md Sazzad H, von Holzen U, Zhang C, Schwarz RE, Awasthi N. Targeted FGFR/VEGFR/PDGFR inhibition with dovitinib enhances the effects of nab-paclitaxel in preclinical gastric cancer models. Cancer Biol Ther 2021;22:619-29. [PMID: 34882068 DOI: 10.1080/15384047.2021.2011642] [Reference Citation Analysis]
88 Ye LP, Mao XL, Zhou XB, Wang Y, Xu SW, He SQ, Qian ZL, Zhang XG, Zhai LJ, Peng JB, Gu BB, Jin XX, Song YQ, Li SW. Cost-effective low-coverage whole-genome sequencing assay for the risk stratification of gastric cancer. World J Gastrointest Oncol 2022; 14(3): 690-702 [DOI: 10.4251/wjgo.v14.i3.690] [Reference Citation Analysis]
89 Sun J, Shen D, Zheng Y, Ren H, Liu H, Chen X, Gao Y. USP8 Inhibitor Suppresses HER-2 Positive Gastric Cancer Cell Proliferation and Metastasis via the PI3K/AKT Signaling Pathway. Onco Targets Ther 2020;13:9941-52. [PMID: 33116578 DOI: 10.2147/OTT.S271496] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
90 Ma G, Zuo S, Liu J. Design of Low-Cost Endoscope Based on Novel Wire-Driven Rotary Valve and Water-Jet Mechanism. Journal of Medical Devices 2021;15:044501. [DOI: 10.1115/1.4052304] [Reference Citation Analysis]
91 Bornschein J, Pritchard DM. Myths and misconceptions in the management of Helicobacter pylori infection. Frontline Gastroenterol 2022;13:245-53. [DOI: 10.1136/flgastro-2021-101826] [Reference Citation Analysis]
92 Zheng G, Sundquist K, Sundquist J, Chen T, Försti A, Hemminki A, Hemminki K. Second Primary Cancers After Gastric Cancer, and Gastric Cancer as Second Primary Cancer. Clin Epidemiol 2021;13:515-25. [PMID: 34239328 DOI: 10.2147/CLEP.S304332] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Lan N, Chen X, Lu Y, Zhou Y, Kong F, Zhao Y, Jiao F, Zhang L, Yuan W. The Impact and Clinical Prediction of Hyperglycemia During Parenteral Nutrition for Nondiabetic Patients After Gastrectomy for Gastric Cancer. Front Nutr 2022;9:807841. [DOI: 10.3389/fnut.2022.807841] [Reference Citation Analysis]
94 Kuang XH, Li J. Dilemma in selection of treatment for preoperative anemia in patients with gastric cancer. Shijie Huaren Xiaohua Zazhi 2022; 30(2): 92-99 [DOI: 10.11569/wcjd.v30.i2.92] [Reference Citation Analysis]
95 Xu Y, Lu J, Tang Y, Xie W, Zhang H, Wang B, Zhang S, Hou W, Zou C, Jiang P, Zhang W. PINK1 deficiency in gastric cancer compromises mitophagy, promotes the Warburg effect, and facilitates M2 polarization of macrophages. Cancer Lett 2021;529:19-36. [PMID: 34979165 DOI: 10.1016/j.canlet.2021.12.032] [Reference Citation Analysis]
96 Wu X, Jiang J, Gu Z, Zhang J, Chen Y, Liu X. Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress. Stem Cell Res Ther 2020;11:345. [PMID: 32771052 DOI: 10.1186/s13287-020-01855-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
97 Awiwi MO, Ramanan RV, Elshikh M, Vikram R. Imaging of Gastric Carcinoma. Part One: Diagnosis and Staging. Journal of Gastrointestinal and Abdominal Radiology 2022;4:194-205. [DOI: 10.1055/s-0041-1735217] [Reference Citation Analysis]
98 Molaparast M, Ehsanimehr S, Kahyaei M, Mahboubi N, Shafiei-irannejad V. Polymeric complex based on poly (styrene-alt-maleic anhydride)- targeted with folic acid for doxorubicin delivery to HT-29 colorectal cancer cells. International Journal of Polymeric Materials and Polymeric Biomaterials. [DOI: 10.1080/00914037.2021.1999953] [Reference Citation Analysis]
99 Alsulaimany FAS, Awan ZA, Almohamady AM, Koumu MI, Yaghmoor BE, Elhady SS, Elfaky MA. Prevalence of Helicobacter pylori Infection and Diagnostic Methods in the Middle East and North Africa Region. Medicina (Kaunas) 2020;56:E169. [PMID: 32283700 DOI: 10.3390/medicina56040169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
100 Linder G, Klevebro F, Edholm D, Johansson J, Lindblad M, Hedberg J. Burden of in-hospital care in oesophageal cancer: national population-based study. BJS Open 2021;5:zrab037. [PMID: 33960365 DOI: 10.1093/bjsopen/zrab037] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 He J, Zhang Z, Yang Y, Ren F, Li J, Zhu S, Ma F, Wu R, Lv Y, He G, Guo B, Chu D. Injectable Self-Healing Adhesive pH-Responsive Hydrogels Accelerate Gastric Hemostasis and Wound Healing. Nanomicro Lett 2021;13:80. [PMID: 34138263 DOI: 10.1007/s40820-020-00585-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
102 Rabben HL, Andersen GT, Olsen MK, Øverby A, Ianevski A, Kainov D, Wang TC, Lundgren S, Grønbech JE, Chen D, Zhao CM. Neural signaling modulates metabolism of gastric cancer. iScience 2021;24:102091. [PMID: 33598644 DOI: 10.1016/j.isci.2021.102091] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
103 Li J, Xie Y, Wang X, Jiang C, Yuan X, Zhang A, Yang L, Liu C, Zou H, Li F, Hu J. Identification of hub genes associated with esophageal cancer progression using bioinformatics analysis. Oncol Lett 2020;20:214. [PMID: 32963620 DOI: 10.3892/ol.2020.12077] [Reference Citation Analysis]
104 Park JS, Choe EA, Park S, Nam CM, Hyung WJ, Noh SH, Lee S, Kim HS, Jung M, Chung HC, Rha SY. Detection of asymptomatic recurrence improves survival of gastric cancer patients. Cancer Med 2021;10:3249-60. [PMID: 33932104 DOI: 10.1002/cam4.3899] [Reference Citation Analysis]
105 Kohoutova D, Banks M, Bures J. Advances in the Aetiology & Endoscopic Detection and Management of Early Gastric Cancer. Cancers (Basel) 2021;13:6242. [PMID: 34944861 DOI: 10.3390/cancers13246242] [Reference Citation Analysis]
106 Chen D, Chen H, Chi L, Fu M, Wang G, Wu Z, Xu S, Sun C, Xu X, Lin L, Cheng J, Jiang W, Dong X, Lu J, Zheng J, Chen G, Li G, Zhuo S, Yan J. Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer. JAMA Netw Open 2021;4:e2136388. [PMID: 34846524 DOI: 10.1001/jamanetworkopen.2021.36388] [Reference Citation Analysis]